I am currently a fourth-year PhD candidate in Biological Sciences at the Institute of Systems, Molecular and Integrative Biology, University of Liverpool, based at Xi’an Jiaotong-Liverpool University. I hold a BSc (2012) and MSc (2015) in Pharmaceutical Sciences from China Pharmaceutical University. Since 2015, I have worked in the biopharmaceutical industry, focusing on tumour biology and immuno-oncology, and contributed to the R&D of antibody-based and ADC anticancer therapeutics. My current research explores molecular mechanisms of cancer progression and therapeutic targeting, combining academic investigation with my industry-informed perspective. I am committed to advancing translational cancer research and fostering cross-sector collaboration.

Tumor Biology and Immuno‑Oncology, including molecular mechanisms of cancer progression, metastasis, and therapeutic resistance, and signal pathway regulation in cancers

 

Translational Cancer Therapy Development, including antibody and antibody‑drug conjugate (ADC) design, target validation, and preclinical evaluation, integrating biopharmaceutical industry strategies with fundamental cancer research

Professional Experience​

Education​